HIV-1 Nef protein: An invitation to a kill

Nature Medicine

Volumn 5, Issue 9, 1999, Pages 985-986

  Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS PROTEIN;

DOWN REGULATION; GENE EXPRESSION; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SHORT SURVEY; T LYMPHOCYTE;

ANIMALS; DOWN-REGULATION; GENE PRODUCTS, NEF; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEINS; MACROPHAGES; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 0032871336     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/12417     Document Type: Short Survey

References (13)

1. Cullen, B.R. HIV-1 auxiliary proteins: Making connections in a dying cell. Cell 93, 685-692 (1998).
2. Kestler, H.W. III et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662 (1991).
3. Swingler, S. et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nature Med. 5, 997-1003 (1999).
4. Lama, J. et al. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9, 622-631 (1999).
5. Ross, T.M. et al. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 9, 613-621 (1999).
6. Collins, K. L. et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401 (1998).
7. Du, Z. et al. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82, 665-674 (1995).
8. Alexander, L. et al. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 Nef alleles in lymphocyte activation. J. Virol. 71, 6094-6099 (1997).
9. Baur, A.S. et al. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384 (1994).
10. Skowronski, J. et al. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12, 703-713 (1993).
11. Saksela, K. et al. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14, 484-491 (1995).
12. Fackler, O.T. et al. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 3, 729-739 (1999).
13. Zhu, T. et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261, 1179-1181 (1993).